Mpox
2023
CDC Update: Potential Risk for New Mpox Cases (May 2023) [PDF - 166 KB]
2022
CDC Update: Managing mpox in Patients Receiving Therapeutics (Nov 2022) [PDF - 226 KB]
JYNNEOS Vaccine VAERS submission (Sept 2022) [PDF - 211 KB]
Tecovirimat (TPOXX) EA-IND Document Reporting for mpox (Aug 2022) [PDF - 226 KB]
Updated Guidance for mpox Countermeasures (Aug 2022) [PDF - 305 KB]
EUA for intradermal administration of JYNNEOS vaccine (Aug 2022) [PDF - 185 KB]
Current Therapeutic Guidance on mpox (Aug 2022) [PDF - 477 KB]
Access to Available mpox Therapies (July 2022) [PDF - 178 KB]
mpox Pre- and Post-Exposure Therapies (June 2022) [PDF - 152 KB]
- IHS mpox PrEP Initiative for Jynneos Vaccine [PDF - 622 KB]
- Policy and Procedure [PDF - 441 KB]
- Flow Chart for Clinic Staff Receiving Phone Calls about mpox [PDF - 222 KB]
- Jynneos Vaccination Documentation [PDF - 481 KB]
- JYNNEOS Smallpox and mpox Vaccine Eligibility and Administration [PDF - 34 KB]
- mpox Vaccine Clinic Worksheet [PDF - 271 KB]
- Providers: mpox Treatment with Techovirimat [PDF - 411 KB]
- Training Resources for Jynneos Intradermal Injection [PDF - 316 KB]
- Competency Assessment for Intradermal Injections [PDF - 721 KB]
- Provider Confirmation Form for Ordering Tecovirimat (TPOXX) [PDF - 422 KB]
